Quote:
Originally Posted by 70 copo
SBR,
Good info!
The following info is a bit sketchy because it is still early - but countries that have experienced Malaria outbreaks in the past are currently pretty much negative for the COVID-19
If this holds then this builds a strong case for population immunity based upon the previous use of Chloroquine phosphate and Hydroxychloroquine. Both Malaria drugs with long approvals and known side effects.
That is why POTUS is now mentioning this drug openly now and Bayer just shipped a large quantity of it to the US a couple of days ago, and so far there is now considerable evidence from several countries (China, S. Korea, France,) that anti-malarial drugs, especially chloroquine, is effective at greatly reducing COVID-19 symptoms, and possibly preventing infection in the first place.
------------------------------------------------------------------------------
The other drug AbbVie’s HIV combo Kaletra (Aluvia) just failed in its 199 patient trial in China. So that one is done.
|
More on this development.
Israeli drug company donating 6M doses of malaria drug to US to combat coronavirus
Israel’s leading drug producer announced Thursday it will donate 6 million doses of anti-malaria drugs to the United States in hopes that it could be helpful treating coronavirus symptoms.
Teva Pharmaceutical Industries says the drug could potentially treat people with the coronavirus and will ship the hydroxychloroquine tablets through wholesalers nationwide by the end of the month and will provide 10 million doses in total.
“We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva Executive Vice President Brendan O’Grady said about the move.